Ann: Mesoblast Reports Positive Type 2 Diabetes T, page-15

re: Ann: Mesoblast Reports Positive Type 2 Di... ..:-)))...ann is very positive!...the cells ARE working...we finally have a treatment coming for DB2!

"The MPCs were safe and well tolerated with no treatment-related adverse events, meeting the trial's primary endpoint."

We have achieved the primary benchmark for this trial - safety and no adverse events. I am not sure guys if you realise how important that is. There are dozens of drugs for different conditions on the market raking billions in earnings which are extremely toxic with huge side affects. To have a safe drug with no side affects is a huge winner. How much improvement we will deliver will depend on each patient condition. And we showed improvement as well..:-)

"61 patients with a mean diabetes duration of 10 years."

That is important as well - ongoing diabetes - and probably getting worst from year to year. These patients are looking at insulin injections one of these days. DB2 is a progressive disease and it is very hard to treat - population in general is lazy and like to eat all the wrong foods....